According to a new analysis “CBD can prevent cardiac oxidative damage in many conditions, such as hypertension, diabetes, or even through the cardiotoxic effects induced by chemotherapy”. This makes CBD “a potential target for future clinical use to minimize the deleterious effects of many pathophysiologies”, states the study which was published in the journal Current …
Category: Studies
Dec 11 2022
Study: Both THC and CBD Improve Wound Healing, May be Valuable As Skin Rejuvenators
A new study published this week by the journal Cells has found that phytocannabinoids such as THC and CBD may be useful in skin rejuvenation and can significantly improve wound healing. The study was conducted by researchers at the University of Lethbridg in Canada, the Universität zu Lübeck in Germany, the Vellore Institute of Technology …
Dec 06 2022
Study: Every $1 of Medical Cannabis Sold Associated With $0.74 – $0.84 in Decreased Alcohol Sales
Medical cannabis sales in Canada are associated with a large decrease in alcohol sales, according to a new study published in the journal Health Policy. Conducted at Brock University in Canada, the full text of the study can be found by clicking here. “The extent to which legalizing cannabis use might lead to increased or …
Dec 04 2022
CB2R Activation Ameliorates Pseudomonas Aeruginosa-Induced Lung Injury and Inflammation
According to a new study published by the journal Respiratory Research, activation of the body’s cannabinoid-2 receptor ameliorates (makes better) pseudomonas aeruginosa-induced lung injury and inflammation, “thus paving the path for new therapeutic avenues against PA pneumonia.” As noted by the study’s abstract, bacterial pneumonia is a major risk factor for acute lung injury (ALI) …
Dec 02 2022
Study: Cannabis Exposure Decreases Need for Blood Pressure Support During General Anesthesia
The prior use of cannabis “results in a decreased need for blood pressure support during general anesthesia”, finds a study published in the peer-reviewed journal Cannabis and Cannabinoids Research, with the full text of the study published on the website for the National Library of Medicine. According to researchers, this retrospective study “focuses on the …
Dec 01 2022
Study: THC and CBN Induced Cell Death in Cholangiocarcinoma (Bile Duct Cancer)
According to a new peer-reviewed study the cannabis compounds THC and CBN (cannabinol) induced apoptosis (cell death) in an animal model of cholangiocarcinoma (bile duct cancer). The study was published in the journal Evidence-Based Complementary and Alternative Medicine, and was conducted by researchers at Rangsit University, Bumrungrad International Hospital and Thammasat University, all in Thailand. …
Nov 28 2022
Study: CBD has Direct Antineoplastic Effects on Lung Cancer Cells
Cannabidiol (CBD) has “direct antineoplastic [cancer treating] effects on lung cancer cells”, according to a new study being published in the upcoming issue of the Iranian Biomedical Journal. The study was epublished ahead of print on the website for the U.S. National Institute of Health. “Lung cancer remains a major factor contributing to morbidity and …
Nov 25 2022
Study: CBD Reduces Seizures That Are Resistant to Common Medications
A new study has found that CBD reduces seizures in patients with Dravet syndrome (SD), Lennox-Gataut syndrome (LGS), or tuberous sclerosis complex (TSC), who are resistant to common medications. Published by the journal Revista da Associação Médica Brasileira and epublished by the National Library of Medicine, the study was conducted by researchers at Medicina Baseada …
Nov 21 2022
Study: Cannabinoids May Induce Immunogenic Cancer Cell Death
Cannabinoids may induce immunogenic cell death indicating they may be useful in combatting cancer. This is according to a new study being published in the upcoming issue of the peer-reviewed journal Cannabis and Cannabinoids Research. The study was epublished by the National Institute of Health, and “is the first demonstration that cannabinoids can induce the …
Nov 20 2022
Study: Oral Cannabinoid Therapy Safe and Effective Against Treatment Refractory Chronic Pain
Oral cannabinoid therapy seems to be safe and at least mildly effective in patients with treatment refractory chronic pain, according to a new European Journal of Pain study. “Cannabinoids are considered a therapeutic option to patients suffering from treatment refractory chronic pain (TRCP) insufficiently relieved by conventional analgesics or experiencing intolerable adverse events (AEs) from …